By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Bioterrorism: Pentagon Goes Back to the Drawing Board
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > Bioterrorism: Pentagon Goes Back to the Drawing Board
Public Health

Bioterrorism: Pentagon Goes Back to the Drawing Board

GlennLaffel
GlennLaffel
Share
4 Min Read
SHARE

The horrifying events of September 11, 2001 and the subsequent weaponized anthrax scare shook-up every American. Officials in charge of homeland defense were particularly shocked. Among other things, it dawned on them that our nation had no good way to defend itself against future bioterrorist attacks.

Soon thereafter, the Pentagon set aside $1 billion to develop treatments for soldiers and civilians who became infected in a bioterrorist attack. The funds went to something called the Transformational Medical Technologies program, which quickly disbursed them to more than 100 universities, drug companies and biotech companies.

The primary goal of the research spawned by these grants was to develop medicines that could neutralize bacteria and viruses that had been specially designed by terrorists to kill people and resist all known therapeutic agents. The infectious agents targeted by the scientists included Ebola, Marburg, Lassa, Sabia, Machupo and Junin.

But now, 5 years after the grants were disbursed, Pentagon officials are pretty much calling the program a bust. Just 2 experimental drugs have shown promise, and they are years away from clinical testing, let alone commercialization.

The major problem, it seems, is technical. It turns out to be easier to increase the lethality of a virus than it is to devise ways to fight it.

“The offensive capabilities outrun the defensive capabilities as the march of biology continues,’’ Richard Danzig, a former Navy secretary and bioterrorism expert said in an interview. “The theory behind [the program] was these same advances should empower the defenses,’’ he explained. “That intuition is worth exploring and investing in, but it is easier to conceive than to execute.’’

A secondary problem should have been anticipated by the Pentagon in advance: for ethical reasons, experimental treatments for nasty germs like these cannot be tested in human clinical trials, yet the FDA requires data from such trials before approving them. The work-around strategy is to test the agents on animals that have been genetically engineered so as to have traits that mimic what is seen in humans, but this process is time-consuming and expensive.

So What Will the Pentagon to Do? Of course the Pentagon cannot walk away from the effort. The threat of bioterrorism remains. So it has set aside an additional $1 billion to develop fast, inexpensive ways to identify (rather than treat) weaponized versions of the germs mentioned above. In all likelihood, many of the same contractors will play a role in the new effort.

Early identification may not sound as sexy as effective treatment, but it can be extraordinarily important. In particular, it allows public health officials or military leaders to institute quarantines, restrict air travel and take related actions in a timelier manner. This lead-time can vastly reduce transmission the infectious agent in the setting of a bioterror attack.

Of course, this strategy doesn’t help folks who have been infected. To this end, the Pentagon holds out hope that byproducts of the new research will eventually help in the development of antidotes.

It’s a lot better than the alternative, which is inaction. Our fingers are crossed for positive results, and we will follow with interest.

TAGGED:bioterrorismpublic health
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

a woman walking on the hallway
6 Easy Healthcare Ways to Sit Less and Move More Every Day
Health
September 9, 2025
Clinical Expertise
Healthcare at a Crossroads: Why Leadership Matters More Than Ever
Global Healthcare
September 9, 2025
travel nurse in north carolina
Balancing Speed and Scope: Choosing the Nursing Degree That Fits Your Goals
Nursing
September 1, 2025
intimacy
How to Keep Intimacy Comfortable as You Age
Relationship and Lifestyle Senior Care
September 1, 2025

You Might also Like

Vitamin E Supplements May be Hazardous to Bone Health

April 3, 2012
siipc14
BusinesseHealthHealth ReformMobile HealthPublic Health

Keeping Patients in the Dark

July 6, 2014

Health Insurance Benefits: Can You Have It Your Way?

August 19, 2014
medical monopoly image
BusinessFinanceHospital AdministrationNewsPublic Health

More Medical Monopoly-Yes, Medical Bills Are Killing Us!

February 21, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?